New study hopes to ease chronic constipation with linaclotide
NCT ID NCT07431957
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests two doses of linaclotide (72 mcg and 145 mcg) against a placebo in 90 adults with chronic constipation. Participants take the drug daily for 8 weeks and record their bowel movements and symptoms. The goal is to see if linaclotide improves bowel function and reduces discomfort better than a placebo.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC CONSTIPATION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Dhaka Medical College
Dhaka, Bangladesh
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can mapping rare genetic variants unlock better care for autism-related disorders?
- Can a simple footstool help you poop better?
- Balloon trick may unlock better bowel training for constipation sufferers
- New study aims to pinpoint hidden cause of chronic constipation
- Ear nerve zap may calm IBS constipation symptoms
- Gut bacteria boost: probiotic shows promise for constipation relief